v3.26.1
NET INCOME (LOSS) PER SHARE
9 Months Ended
Jul. 03, 2026
Earnings Per Share [Abstract]  
NET INCOME (LOSS) PER SHARE NET INCOME (LOSS) PER SHARE
    Basic net income (loss) per common share is computed by dividing the net income (loss) for the period by the weighted average number of shares of common stock outstanding during the reporting period. Diluted net income (loss) per common share reflects the effects of potentially dilutive securities, which is computed by dividing the sum of net income (loss) and any adjustments to net income by the sum of the weighted average number of common shares outstanding and dilutive common shares.
    A reconciliation of the numerator and denominator used in the calculation of basic and diluted net income (loss) per common share is as follows:
Three Months EndedNine Months Ended
(In millions, except per share amounts)
July 3, 2026July 4, 2025July 3, 2026July 4, 2025
Net income (loss) per share - basic
Net income (loss) attributable to Varex$15.7 $(89.1)$9.9 $(82.5)
Basic weighted average shares outstanding
42.1 41.5 42.0 41.3 
Basic net income (loss) per share attributable to Varex$0.37 $(2.15)$0.24 $(2.00)
  
Net income (loss) per share - diluted
Net income (loss) attributable to Varex$15.7 $(89.1)$9.9 $(82.5)
  
Basic weighted average shares outstanding42.1 41.5 42.0 41.3 
Dilutive effect of share-based awards and other0.5 — 0.5 — 
Diluted weighted average shares outstanding
42.6 41.5 42.5 41.3 
Diluted net income (loss) per share attributable to Varex$0.37 $(2.15)$0.23 $(2.00)
  
Anti-dilutive share summary
Share-based awards and other
2.0 3.5 2.1 3.4 
Warrants— 9.6 — 9.6 
Total anti-dilutive shares2.0 13.1 2.1 13.0 
    Potentially dilutive shares, which are based on the weighted-average shares of common stock underlying stock options, unvested stock awards, purchase rights granted under the employee stock purchase plan, warrants, and convertible notes using the treasury stock method or the if-converted method, as applicable, are included when calculating diluted net income (loss) per share attributable to Varex when their effect is dilutive.